Maxwell Finland Professor of Medicine, Emeritus
Pai SM, Shukla UA, Grasela TH, Knupp CA, Dolin R, Valentine FT, McLaren C, Liebman HA, Martin RR, Pittman KA
Population pharmacokinetic analysis of didanosine (2',3'-dideoxyinosine) plasma concentrations obtained in phase I clinical trials in patients with AIDS or AIDS-related complex. J Clin Pharmacol. 1992 Mar; 32(3):242-7.
Population pharmacokinetic analysis of didanosine (2',3'-dideoxyinosine) plasma concentrations obtained in phase I clinical trials in patients with AIDS or AIDS-related complex.
Dolin R, Blacklow NR, Malmgren RA, Chanock RM
Establishment of human fetal intestinal organ cultures for growth of viruses. J Infect Dis. 1970 Sep; 122(3):227-31.
Establishment of human fetal intestinal organ cultures for growth of viruses.
Reichman RC, Ginsberg M, Barrett-Connor E, Wyborny C, Connor JD, Redfield D, Savoia MC, Richman DD, Oxman MN, Dandliker PS, Badger GJ, Ashikaga T, Dolin R
Controlled trial of oral acyclovir in the therapy of recurrent herpes simplex genitalis. A preliminary report. Am J Med. 1982 Jul 20; 73(1A):338-41.
Controlled trial of oral acyclovir in the therapy of recurrent herpes simplex genitalis. A preliminary report.
Demeter LM, Nawaz T, Morse G, Dolin R, Dexter A, Gerondelis P, Reichman RC
Development of zidovudine resistance mutations in patients receiving prolonged didanosine monotherapy. J Infect Dis. 1995 Dec; 172(6):1480-5.
Development of zidovudine resistance mutations in patients receiving prolonged didanosine monotherapy.
Dolin R, Blacklow NR, DuPont H, Buscho RF, Wyatt RG, Kasel JA, Hornick R, Chanock RM
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
Biological properties of Norwalk agent of acute infectious nonbacterial gastroenteritis. Proc Soc Exp Biol Med. 1972 Jun; 140(2):578-83.
Biological properties of Norwalk agent of acute infectious nonbacterial gastroenteritis.
Reichman RC, Tejani N, Lambert JL, Strussenberg J, Bonnez W, Blumberg B, Epstein L, Dolin R
Didanosine (ddI) and zidovudine (ZDV) susceptibilities of human immunodeficiency virus (HIV) isolates from long-term recipients of ddI. Antiviral Res. 1993 Apr; 20(4):267-77.
Didanosine (ddI) and zidovudine (ZDV) susceptibilities of human immunodeficiency virus (HIV) isolates from long-term recipients of ddI.
el-Daher N, Keefer MC, Reichman RC, Dolin R, Roberts NJ
Persisting human immunodeficiency virus type 1 gp160-specific human T lymphocyte responses including CD8+ cytotoxic activity after receipt of envelope vaccines. J Infect Dis. 1993 Aug; 168(2):306-13.
Persisting human immunodeficiency virus type 1 gp160-specific human T lymphocyte responses including CD8+ cytotoxic activity after receipt of envelope vaccines.
Finkelstein DM, Williams PL, Molenberghs G, Feinberg J, Powderly WG, Kahn J, Dolin R, Cotton D
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association
Patterns of opportunistic infections in patients with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 May 01; 12(1):38-45.
J Acquir Immune Defic Syndr Hum Retrovirol
Patterns of opportunistic infections in patients with HIV infection.
McLaren C, Rozencweig M, Beltangady M, Nicaise C, Yarchoan R, Dolin R, Allan JD, Cooley TP, Seidlin M, Smaldone LF
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Longitudinal analysis of responses to oral didanosine therapy following zidovudine therapy in advanced infection with human immunodeficiency virus. Clin Infect Dis. 1993 Feb; 16 Suppl 1:S32-9.
Longitudinal analysis of responses to oral didanosine therapy following zidovudine therapy in advanced infection with human immunodeficiency virus.
Gorse GJ, Keefer MC, Belshe RB, Matthews TJ, Forrest BD, Hsieh RH, Koff WC, Hanson CV, Dolin R, Weinhold KJ, Frey SE, Ketter N, Fast PE
A dose-ranging study of a prototype synthetic HIV-1MN V3 branched peptide vaccine. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group. J Infect Dis. 1996 Feb; 173(2):330-9.
A dose-ranging study of a prototype synthetic HIV-1MN V3 branched peptide vaccine. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.
Dolin R, Wise TG, Mazur MH, Tuazon CU, Ennis FA
Immunogenicity and reactogenicity of influenza A/New Jersey/76 virus vaccines in normal adults. J Infect Dis. 1977 Dec; 136 Suppl:S435-42.
Immunogenicity and reactogenicity of influenza A/New Jersey/76 virus vaccines in normal adults.
Wilck MB, Seaman MS, Baden LR, Walsh SR, Grandpre LE, Devoy C, Giri A, Kleinjan JA, Noble LC, Stevenson KE, Kim HT, Dolin R
Safety and immunogenicity of modified vaccinia Ankara (ACAM3000): effect of dose and route of administration. J Infect Dis. 2010 May 01; 201(9):1361-70.
Safety and immunogenicity of modified vaccinia Ankara (ACAM3000): effect of dose and route of administration.
Baden LR, Walsh SR, Seaman MS, Cohen YZ, Johnson JA, Licona JH, Filter RD, Kleinjan JA, Gothing JA, Jennings J, Peter L, Nkolola J, Abbink P, Borducchi EN, Kirilova M, Stephenson KE, Pegu P, Eller MA, Trinh HV, Rao M, Ake JA, Sarnecki M, Nijs S, Callewaert K, Schuitemaker H, Hendriks J, Pau MG, Tomaka F, Korber BT, Alter G, Dolin R, Earl PL, Moss B, Michael NL, Robb ML, Barouch DH
First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector. J Infect Dis. 2018 07 13; 218(4):633-644.
First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector.
Influenza--interpandemic as well as pandemic disease. N Engl J Med. 2005 Dec 15; 353(24):2535-7.
Influenza--interpandemic as well as pandemic disease.
Grandpre LE, Duke-Cohan JS, Ewald BA, Devoy C, Barouch DH, Letvin NL, Reinherz EL, Baden LR, Dolin R, Seaman MS
Immunogenicity of recombinant Modified Vaccinia Ankara following a single or multi-dose vaccine regimen in rhesus monkeys. Vaccine. 2009 Mar 04; 27(10):1549-56.
Immunogenicity of recombinant Modified Vaccinia Ankara following a single or multi-dose vaccine regimen in rhesus monkeys.
Thornhill TS, Wyatt RG, Kalica AR, Dolin R, Chanock RM, Kapikian AZ
Detection by immune electron microscopy of 26- to 27-nm viruslike particles associated with two family outbreaks of gastroenteritis. J Infect Dis. 1977 Jan; 135(1):20-7.
Detection by immune electron microscopy of 26- to 27-nm viruslike particles associated with two family outbreaks of gastroenteritis.
Wyatt RG, Dolin R, Blacklow NR, DuPont HL, Buscho RF, Thornhill TS, Kapikian AZ, Chanock RM
Comparison of three agents of acute infectious nonbacterial gastroenteritis by cross-challenge in volunteers. J Infect Dis. 1974 Jun; 129(6):709-14.
Comparison of three agents of acute infectious nonbacterial gastroenteritis by cross-challenge in volunteers.
Skevakis L, Frasch CE, Zahradnik JM, Dolin R
Class-specific human bactericidal antibodies to capsular and noncapsular surface antigens of Neisseria meningitidis. J Infect Dis. 1984 Mar; 149(3):387-96.
Class-specific human bactericidal antibodies to capsular and noncapsular surface antigens of Neisseria meningitidis.
Editorial commentary: Perspectives on the role of immunization against influenza in HIV-infected patients. Clin Infect Dis. 2011 Jan 01; 52(1):147-9.
Editorial commentary: Perspectives on the role of immunization against influenza in HIV-infected patients.
Genital lesions and aseptic meningitis. Hosp Pract (Off Ed). 1987 Oct 30; 22(10A):27-37.
Enzyme-linked immunosorbent assays for Snow Mountain and Norwalk agents of viral gastroenteritis. J Clin Microbiol. 1986 Sep; 24(3):456-9.
Enzyme-linked immunosorbent assays for Snow Mountain and Norwalk agents of viral gastroenteritis.
Serum antibody responses in naturally occurring influenza A virus infection determined by enzyme-linked immunosorbent assay, hemagglutination inhibition, and complement fixation. J Clin Microbiol. 1983 Dec; 18(6):1345-50.
Serum antibody responses in naturally occurring influenza A virus infection determined by enzyme-linked immunosorbent assay, hemagglutination inhibition, and complement fixation.
Cole J, Dolin R, Fahrner K, Gallenson N, Hall J, Harris W
Retinofugal pathways from albino eyes embryonically transplanted to normal and albino axolotls. Brain Res. 1982 Nov; 281(3):346-9.
Retinofugal pathways from albino eyes embryonically transplanted to normal and albino axolotls.
Absence of detectable interferon in jejunal biopsies, jejunal aspirates, and sera in experimentally induced viral gastroenteritis in man. Proc Soc Exp Biol Med. 1975 Nov; 150(2):337-9.
Absence of detectable interferon in jejunal biopsies, jejunal aspirates, and sera in experimentally induced viral gastroenteritis in man.
Churchyard GJ, Morgan C, Adams E, Hural J, Graham BS, Moodie Z, Grove D, Gray G, Bekker LG, McElrath MJ, Tomaras GD, Goepfert P, Kalams S, Baden LR, Lally M, Dolin R, Blattner W, Kalichman A, Figueroa JP, Pape J, Schechter M, Defawe O, De Rosa SC, Montefiori DC, Nabel GJ, Corey L, Keefer MC
A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204). PLoS One. 2011; 6(8):e21225.
A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204).
A new class of anti-HIV therapy and new challenges. N Engl J Med. 2008 Oct 02; 359(14):1509-11.
A new class of anti-HIV therapy and new challenges.
Ultrastructural study of viral replication in human fetal intestinal organ culture. Arch Gesamte Virusforsch. 1973; 40(3):341-9.
Ultrastructural study of viral replication in human fetal intestinal organ culture.
Agus SG, Dolin R, Wyatt RG, Tousimis AJ, Northrup RS
Acute infectious nonbacterial gastroenteritis: intestinal histopathology. Histologic and enzymatic alterations during illness produced by the Norwalk agent in man. Ann Intern Med. 1973 Jul; 79(1):18-25.
Acute infectious nonbacterial gastroenteritis: intestinal histopathology. Histologic and enzymatic alterations during illness produced by the Norwalk agent in man.
Dolin R, Amato DA, Fischl MA, Pettinelli C, Beltangady M, Liou SH, Brown MJ, Cross AP, Hirsch MS, Hardy WD
Zidovudine compared with didanosine in patients with advanced HIV type 1 infection and little or no previous experience with zidovudine. AIDS Clinical Trials Group. Arch Intern Med. 1995 May 08; 155(9):961-74.
Zidovudine compared with didanosine in patients with advanced HIV type 1 infection and little or no previous experience with zidovudine. AIDS Clinical Trials Group.
Beltangady M, Knupp CA, Gustafson N, Barbhaiya RH, Dolin R, Seidlin M, Cooley TP, Rozencweig M
Relation between plasma concentrations of didanosine and markers of antiviral efficacy in adults with AIDS or AIDS-related complex. Clin Infect Dis. 1993 Feb; 16 Suppl 1:S26-31.
Relation between plasma concentrations of didanosine and markers of antiviral efficacy in adults with AIDS or AIDS-related complex.
Belshe RB, Clements ML, Dolin R, Graham BS, McElrath J, Gorse GJ, Schwartz D, Keefer MC, Wright P, Corey L
Safety and immunogenicity of a fully glycosylated recombinant gp160 human immunodeficiency virus type 1 vaccine in subjects at low risk of infection. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group Network. J Infect Dis. 1993 Dec; 168(6):1387-95.
Safety and immunogenicity of a fully glycosylated recombinant gp160 human immunodeficiency virus type 1 vaccine in subjects at low risk of infection. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group Network.
Transactions of the American Clinical and Climatological Association
Current concepts of control measures for influenza. Trans Am Clin Climatol Assoc. 1990; 101:227-33.
Current concepts of control measures for influenza.
Schooley RT, Haynes BF, Grouse J, Payling-Wright C, Fauci AS, Dolin R
Development of suppressor T lymphocytes for Epstein-Barr virus-induced B-lymphocyte outgrowth during acute infectious mononucleosis: assessment by two quantitative systems. Blood. 1981 Mar; 57(3):510-7.
Development of suppressor T lymphocytes for Epstein-Barr virus-induced B-lymphocyte outgrowth during acute infectious mononucleosis: assessment by two quantitative systems.
Dolin R, Reichman RC, Roessner KD, Tralka TS, Schooley RT, Gary W, Morens D
Detection by immune electron microscopy of the Snow Mountain agent of acute viral gastroenteritis. J Infect Dis. 1982 Aug; 146(2):184-9.
Detection by immune electron microscopy of the Snow Mountain agent of acute viral gastroenteritis.
Dolin R, Levy AG, Wyatt RG, Thornhill TS, Gardner JD
Viral gastroenteritis induced by the Hawaii agent. Jejunal histopathology and serologic response. Am J Med. 1975 Dec; 59(6):761-8.
Viral gastroenteritis induced by the Hawaii agent. Jejunal histopathology and serologic response.
Dolin R, Reichman RC, Madore HP, Maynard R, Linton PN, Webber-Jones J
A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. N Engl J Med. 1982 Sep 02; 307(10):580-4.
A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection.
Lambert JS, Seidlin M, Valentine FT, Reichman RC, Dolin R
Didanosine: long-term follow-up of patients in a phase 1 study. Clin Infect Dis. 1993 Feb; 16 Suppl 1:S40-5.
Didanosine: long-term follow-up of patients in a phase 1 study.
Barouch DH, Liu J, Peter L, Abbink P, Iampietro MJ, Cheung A, Alter G, Chung A, Dugast AS, Frahm N, McElrath MJ, Wenschuh H, Reimer U, Seaman MS, Pau MG, Weijtens M, Goudsmit J, Walsh SR, Dolin R, Baden LR
Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001). J Infect Dis. 2013 Jan 15; 207(2):248-56.
Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001).
Baden LR, Walsh SR, Seaman MS, Tucker RP, Krause KH, Patel A, Johnson JA, Kleinjan J, Yanosick KE, Perry J, Zablowsky E, Abbink P, Peter L, Iampietro MJ, Cheung A, Pau MG, Weijtens M, Goudsmit J, Swann E, Wolff M, Loblein H, Dolin R, Barouch DH
First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001). J Infect Dis. 2013 Jan 15; 207(2):240-7.
First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001).
Walsh SR, Seaman MS, Grandpre LE, Charbonneau C, Yanosick KE, Metch B, Keefer MC, Dolin R, Baden LR
Impact of anti-orthopoxvirus neutralizing antibodies induced by a heterologous prime-boost HIV-1 vaccine on insert-specific immune responses. Vaccine. 2012 Dec 17; 31(1):114-9.
Impact of anti-orthopoxvirus neutralizing antibodies induced by a heterologous prime-boost HIV-1 vaccine on insert-specific immune responses.
Characterization of the Snow Mountain agent of viral gastroenteritis. J Virol. 1986 May; 58(2):487-92.
Characterization of the Snow Mountain agent of viral gastroenteritis.
Guest C, Spitalny KC, Madore HP, Pray K, Dolin R, Herrmann JE, Blacklow NR
Foodborne Snow Mountain agent gastroenteritis in a school cafeteria. Pediatrics. 1987 Apr; 79(4):559-63.
Foodborne Snow Mountain agent gastroenteritis in a school cafeteria.
Lymphocyte blastogenic responses to influenza virus antigens after influenza infection and vaccination in humans. Infect Immun. 1978 Mar; 19(3):867-74.
Lymphocyte blastogenic responses to influenza virus antigens after influenza infection and vaccination in humans.
Whitley RJ, Soong SJ, Hirsch MS, Karchmer AW, Dolin R, Galasso G, Dunnick JK, Alford CA
Herpes simplex encephalitis: vidarabine therapy and diagnostic problems. N Engl J Med. 1981 Feb 05; 304(6):313-8.
Herpes simplex encephalitis: vidarabine therapy and diagnostic problems.
Graham BS, Gorse GJ, Schwartz DH, Keefer MC, McElrath MJ, Matthews TJ, Wright PF, Belshe RB, Clements ML, Dolin R
Determinants of antibody response after recombinant gp160 boosting in vaccinia-naive volunteers primed with gp160-recombinant vaccinia virus. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Clinical Trials Network. J Infect Dis. 1994 Oct; 170(4):782-6.
Determinants of antibody response after recombinant gp160 boosting in vaccinia-naive volunteers primed with gp160-recombinant vaccinia virus. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Clinical Trials Network.
Belshe RB, Graham BS, Keefer MC, Gorse GJ, Wright P, Dolin R, Matthews T, Weinhold K, Bolognesi DP, Sposto R
Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network. JAMA. 1994 Aug 10; 272(6):475-80.
Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network.
Amantadine and influenza A. Am Fam Physician. 1979 Jan; 19(1):127-30.
Quinnan GV, Schooley R, Dolin R, Ennis FA, Gross P, Gwaltney JM
Serologic responses and systemic reactions in adults after vaccination with monovalent A/USSR/77 and trivalent A/USSR/77, A/Texas/77, B/Hong Kong/72 influenza vaccines. Rev Infect Dis. 1983 Jul-Aug; 5(4):748-57.
Serologic responses and systemic reactions in adults after vaccination with monovalent A/USSR/77 and trivalent A/USSR/77, A/Texas/77, B/Hong Kong/72 influenza vaccines.
Whitley RJ, Soong SJ, Dolin R, Betts R, Linnemann C, Alford CA
Early vidarabine therapy to control the complications of herpes zoster in immunosuppressed patients. N Engl J Med. 1982 Oct 14; 307(16):971-5.
Early vidarabine therapy to control the complications of herpes zoster in immunosuppressed patients.
Carter BJ, Koczot FJ, Garrison J, Rose JA, Dolin R
Separate helper functions provided by adenovirus for adenovirus-associated virus multiplication. Nat New Biol. 1973 Jul 18; 244(133):71-3.
Separate helper functions provided by adenovirus for adenovirus-associated virus multiplication.
Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors. Expert Rev Vaccines. 2011 Aug; 10(8):1221-40.
Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors.
Lymphocyte responses to herpes simplex virus isolates from patients with primary and recurrent herpes simplex genitalis. Am J Med. 1982 Jul 20; 73(1A):86-90.
Lymphocyte responses to herpes simplex virus isolates from patients with primary and recurrent herpes simplex genitalis.
Journal of the American Veterinary Medical Association
Norwalk agent-like particles associated with gastroenteritis in human beings. J Am Vet Med Assoc. 1978 Sep 01; 173(5 Pt 2):615-9.
Norwalk agent-like particles associated with gastroenteritis in human beings.
Schacter LP, Rozencweig M, Beltangady M, Allan JD, Canetta R, Cooley TP, Dolin R, Kelley S, Lambert J, Liebman HA
Effects of therapy with didanosine on hematologic parameters in patients with advanced human immunodeficiency virus disease. Blood. 1992 Dec 15; 80(12):2969-76.
Effects of therapy with didanosine on hematologic parameters in patients with advanced human immunodeficiency virus disease.
Kapikian AZ, Wyatt RG, Levine MM, Yolken RH, VanKirk DH, Dolin R, Greenberg HB, Chanock RM
Oral administration of human rotavirus to volunteers: induction of illness and correlates of resistance. J Infect Dis. 1983 Jan; 147(1):95-106.
Oral administration of human rotavirus to volunteers: induction of illness and correlates of resistance.
Reichman RC, Badger GJ, Guinan ME, Nahmias AJ, Keeney RE, Davis LG, Ashikaga T, Dolin R
Topically administered acyclovir in the treatment of recurrent herpes simplex genitalis: a controlled trial. J Infect Dis. 1983 Feb; 147(2):336-40.
Topically administered acyclovir in the treatment of recurrent herpes simplex genitalis: a controlled trial.
Internet medical resources. Ann Intern Med. 1996 Feb 01; 124(3):375.
Girod JC, Reichman RC, Winn WC, Klaucke DN, Vogt RL, Dolin R
Pneumonic and nonpneumonic forms of legionellosis. The result of a common-source exposure to Legionella pneumophila. Arch Intern Med. 1982 Mar; 142(3):545-7.
Pneumonic and nonpneumonic forms of legionellosis. The result of a common-source exposure to Legionella pneumophila.
Treanor JJ, Betts RF, Erb SM, Roth FK, Dolin R
Intranasally administered interferon as prophylaxis against experimentally induced influenza A virus infection in humans. J Infect Dis. 1987 Aug; 156(2):379-83.
Intranasally administered interferon as prophylaxis against experimentally induced influenza A virus infection in humans.
Brondum J, Spitalny KC, Vogt RL, Godlewski K, Madore HP, Dolin R
Snow Mountain agent associated with an outbreak of gastroenteritis in Vermont. J Infect Dis. 1985 Oct; 152(4):834-7.
Snow Mountain agent associated with an outbreak of gastroenteritis in Vermont.
Dolin R, Blacklow NR, DuPont H, Formal S, Buscho RF, Kasel JA, Chames RP, Hornick R, Chanock RM
Transmission of acute infectious nonbacterial gastroenteritis to volunteers by oral administration of stool filtrates. J Infect Dis. 1971 Mar; 123(3):307-12.
Transmission of acute infectious nonbacterial gastroenteritis to volunteers by oral administration of stool filtrates.
Mascola JR, Snyder SW, Weislow OS, Belay SM, Belshe RB, Schwartz DH, Clements ML, Dolin R, Graham BS, Gorse GJ, Keefer MC, McElrath MJ, Walker MC, Wagner KF, McNeil JG, McCutchan FE, Burke DS
Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group. J Infect Dis. 1996 Feb; 173(2):340-8.
Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.
Christy C, Madore HP, Pichichero ME, Gala C, Pincus P, Vosefski D, Hoshino Y, Kapikian A, Dolin R
The Pediatric infectious disease journal
Field trial of rhesus rotavirus vaccine in infants. Pediatr Infect Dis J. 1988 Sep; 7(9):645-50.
Field trial of rhesus rotavirus vaccine in infants.
Mertz GJ, Critchlow CW, Benedetti J, Reichman RC, Dolin R, Connor J, Redfield DC, Savoia MC, Richman DD, Tyrrell DL
Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection. JAMA. 1984 Sep 07; 252(9):1147-51.
Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection.
Levy AG, Widerlite L, Schwartz CJ, Dolin R, Blacklow NR, Gardner JD, Kimberg DV, Trier JS
Jejunal adenylate cyclase activity in human subjects during viral gastroenteritis. Gastroenterology. 1976 Mar; 70(3):321-5.
Jejunal adenylate cyclase activity in human subjects during viral gastroenteritis.
Murphy BR, Clements ML, Madore HP, Steinberg J, O'Donnell S, Betts R, Demico D, Reichman RC, Dolin R, Maassab HF
Dose response of cold-adapted, reassortant influenza A/California/10/78 virus (H1N1) in adult volunteers. J Infect Dis. 1984 May; 149(5):816.
Dose response of cold-adapted, reassortant influenza A/California/10/78 virus (H1N1) in adult volunteers.
Dolin R, Richman DD, Murphy BR, Fauci AS
Cell-mediated immune responses in humans after induced infection with influenza A virus. J Infect Dis. 1977 May; 135(5):714-9.
Cell-mediated immune responses in humans after induced infection with influenza A virus.
Snyder MH, Betts RF, DeBorde D, Tierney EL, Clements ML, Herrington D, Sears SD, Dolin R, Maassab HF, Murphy BR
Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines. J Virol. 1988 Feb; 62(2):488-95.
Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines.
Journal of the National Cancer Institute
Herpesvirus saimiri: enhancement of adenovirus-associated virus. J Natl Cancer Inst. 1973 Jan; 50(1):205-8.
Herpesvirus saimiri: enhancement of adenovirus-associated virus.
Berg RA, Yolken RH, Rennard SI, Dolin R, Murphy BR, Straus SE
New enzyme immunoassays for measurement of influenza A/Victoria/3/75 virus in nasal washes. Lancet. 1980 Apr 19; 1(8173):851-3.
New enzyme immunoassays for measurement of influenza A/Victoria/3/75 virus in nasal washes.
Whitley RJ, Soong SJ, Dolin R, Galasso GJ, Ch'ien LT, Alford CA
Journal of the Medical Association of the State of Alabama
Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. J Med Assoc State Ala. 1977 Sep; 47(3):37-42, 66.
Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis.
Lymphocyte populations in acute viral gastroenteritis. Infect Immun. 1976 Aug; 14(2):422-8.
Lymphocyte populations in acute viral gastroenteritis.
William Bosworth Castle Professor of Medicine
Elizabeth G. and Gary J. Nabel Family Professor Professor of Medicine
Remdesivir - An Important First Step. N Engl J Med. 2020 11 05; 383(19):1886-1887.
Oganezova K, Fontana-Martinez EJ, Gothing JA, Pandit A, Kwara E, Yanosick K, Dragavon J, Goecker EA, Maenza J, Espy N, Tomaka F, Lavreys L, Allen M, D'Souza P, Hural J, Coombs RW, Dolin R, Seaman MS, Walsh SR, Baden LR
Poststudy Point-of-Care Oral Fluid Testing in Human Immunodeficiency Virus-1 Vaccinees. Open Forum Infect Dis. 2021 Jan; 8(1):ofaa606.
Poststudy Point-of-Care Oral Fluid Testing in Human Immunodeficiency Virus-1 Vaccinees.
The quadrivalent approach to influenza vaccination. J Infect Dis. 2013 Aug 15; 208(4):539-40.
The quadrivalent approach to influenza vaccination.
Novel HIV vaccine strategies: overview and perspective. Ther Adv Vaccines. 2013 Sep; 1(3):99-112.
Novel HIV vaccine strategies: overview and perspective.
Baden LR, Walsh SR, Seaman MS, Johnson JA, Tucker RP, Kleinjan JA, Gothing JA, Engelson BA, Carey BR, Oza A, Bajimaya S, Peter L, Bleckwehl C, Abbink P, Pau MG, Weijtens M, Kunchai M, Swann EM, Wolff M, Dolin R, Barouch DH
First-in-human evaluation of a hexon chimeric adenovirus vector expressing HIV-1 Env (IPCAVD 002). J Infect Dis. 2014 Oct 01; 210(7):1052-61.
First-in-human evaluation of a hexon chimeric adenovirus vector expressing HIV-1 Env (IPCAVD 002).
Baden LR, Liu J, Li H, Johnson JA, Walsh SR, Kleinjan JA, Engelson BA, Peter L, Abbink P, Milner DA, Golden KL, Viani KL, Stachler MD, Chen BJ, Pau MG, Weijtens M, Carey BR, Miller CA, Swann EM, Wolff M, Loblein H, Seaman MS, Dolin R, Barouch DH
Induction of HIV-1-specific mucosal immune responses following intramuscular recombinant adenovirus serotype 26 HIV-1 vaccination of humans. J Infect Dis. 2015 Feb 15; 211(4):518-28.
Induction of HIV-1-specific mucosal immune responses following intramuscular recombinant adenovirus serotype 26 HIV-1 vaccination of humans.
Baden LR, Karita E, Mutua G, Bekker LG, Gray G, Page-Shipp L, Walsh SR, Nyombayire J, Anzala O, Roux S, Laher F, Innes C, Seaman MS, Cohen YZ, Peter L, Frahm N, McElrath MJ, Hayes P, Swann E, Grunenberg N, Grazia-Pau M, Weijtens M, Sadoff J, Dally L, Lombardo A, Gilmour J, Cox J, Dolin R, Fast P, Barouch DH, Laufer DS
Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial. Ann Intern Med. 2016 Mar 01; 164(5):313-22.
Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial.
New England Regional Center of Excellence in Biodefense and Emerging Infectious D
Novel Ad/MVA and Ad/Protein HIV-1 Vaccines
(CHAVI) Center for HIV/AIDS Vaccine Immunology
Harvard Medical School Vaccine Clinical Trials Unit
Novel Adenovirus Vector-Based Vaccines for HIV-1
Novel Heterologous Adenovirus Prime-Boost HIV-1 Vaccine
TRAINING IN IMMUNOLOGY AND INFECTIOUS DISEASES
Keefer MC, Graham BS, McElrath MJ, Matthews TJ, Stablein DM, Corey L, Wright PF, Lawrence D, Fast PE, Weinhold K, Hsieh RH, Chernoff D, Dekker C, Dolin R
Safety and immunogenicity of Env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59. NIAID AIDS Vaccine Evaluation Group. AIDS Res Hum Retroviruses. 1996 May 20; 12(8):683-93.
Safety and immunogenicity of Env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59. NIAID AIDS Vaccine Evaluation Group.
Welles SL, Jackson JB, Yen-Lieberman B, Demeter L, Japour AJ, Smeaton LM, Johnson VA, Kuritzkes DR, D'Aquila RT, Reichelderfer PA, Richman DD, Reichman R, Fischl M, Dolin R, Coombs RW, Kahn JO, McLaren C, Todd J, Kwok S, Crumpacker CS
Prognostic value of plasma human immunodeficiency virus type 1 (HIV-1) RNA levels in patients with advanced HIV-1 disease and with little or no prior zidovudine therapy. AIDS Clinical Trials Group Protocol 116A/116B/117 Team. J Infect Dis. 1996 Oct; 174(4):696-703.
Prognostic value of plasma human immunodeficiency virus type 1 (HIV-1) RNA levels in patients with advanced HIV-1 disease and with little or no prior zidovudine therapy. AIDS Clinical Trials Group Protocol 116A/116B/117 Team.
Madore HP, Christy C, Pichichero M, Long C, Pincus P, Vosefsky D, Kapikian AZ, Dolin R
Field trial of rhesus rotavirus or human-rhesus rotavirus reassortant vaccine of VP7 serotype 3 or 1 specificity in infants. The Elmwood, Panorama, and Westfall Pediatric Groups. J Infect Dis. 1992 Aug; 166(2):235-43.
Field trial of rhesus rotavirus or human-rhesus rotavirus reassortant vaccine of VP7 serotype 3 or 1 specificity in infants. The Elmwood, Panorama, and Westfall Pediatric Groups.
Infectious disease clinics of North America
HIV vaccines for prevention of infection and disease in humans. Infect Dis Clin North Am. 2000 Dec; 14(4):1001-16.
HIV vaccines for prevention of infection and disease in humans.
Gupta K, Hudgens M, Corey L, McElrath MJ, Weinhold K, Montefiori DC, Gorse GJ, Frey SE, Keefer MC, Evans TG, Dolin R, Schwartz DH, Harro C, Graham B, Spearman PW, Mulligan M, Goepfert P
Journal of acquired immune deficiency syndromes (1999)
Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS Vaccine Evaluation Group Protocol 022A. J Acquir Immune Defic Syndr. 2002 Mar 01; 29(3):254-61.
Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS Vaccine Evaluation Group Protocol 022A.
Reichman RC, Dolin R, Vincent MM, Fauci AS
Cell-mediated cytotoxicity in recurrent herpes simplex virus infections in man. Proc Soc Exp Biol Med. 1977 Sep; 155(4):571-6.
Cell-mediated cytotoxicity in recurrent herpes simplex virus infections in man.
Transmission of acute infectious nonbacterial gastroenteritis to volunteers by oral administration of stool filtrates. 1971. J Infect Dis. 2004 Jun 01; 189(11):2142-7, discussion 2139-41.
Transmission of acute infectious nonbacterial gastroenteritis to volunteers by oral administration of stool filtrates. 1971.
Gordon SM, Oshiro LS, Jarvis WR, Donenfeld D, Ho MS, Taylor F, Greenberg HB, Glass R, Madore HP, Dolin R
Foodborne Snow Mountain agent gastroenteritis with secondary person-to-person spread in a retirement community. Am J Epidemiol. 1990 Apr; 131(4):702-10.
Foodborne Snow Mountain agent gastroenteritis with secondary person-to-person spread in a retirement community.
Drusano GL, Yuen GJ, Lambert JS, Seidlin M, Dolin R, Valentine FT
Relationship between dideoxyinosine exposure, CD4 counts, and p24 antigen levels in human immunodeficiency virus infection. A phase I trial. Ann Intern Med. 1992 Apr 01; 116(7):562-6.
Relationship between dideoxyinosine exposure, CD4 counts, and p24 antigen levels in human immunodeficiency virus infection. A phase I trial.
Graham BS, McElrath MJ, Connor RI, Schwartz DH, Gorse GJ, Keefer MC, Mulligan MJ, Matthews TJ, Wolinsky SM, Montefiori DC, Vermund SH, Lambert JS, Corey L, Belshe RB, Dolin R, Wright PF, Korber BT, Wolff MC, Fast PE
Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection Group. J Infect Dis. 1998 Feb; 177(2):310-9.
Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection Group.
Clements-Mann ML, Weinhold K, Matthews TJ, Graham BS, Gorse GJ, Keefer MC, McElrath MJ, Hsieh RH, Mestecky J, Zolla-Pazner S, Mascola J, Schwartz D, Siliciano R, Corey L, Wright PF, Belshe R, Dolin R, Jackson S, Xu S, Fast P, Walker MC, Stablein D, Excler JL, Tartaglia J, Paoletti E
Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group. J Infect Dis. 1998 May; 177(5):1230-46.
Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group.
Kapikian AZ, Vesikari T, Ruuska T, Madore HP, Christy C, Dolin R, Flores J, Green KY, Davidson BL, Gorziglia M
Advances in experimental medicine and biology
An update on the "Jennerian" and modified "Jennerian" approach to vaccination of infants and young children against rotavirus diarrhea. Adv Exp Med Biol. 1992; 327:59-69.
An update on the "Jennerian" and modified "Jennerian" approach to vaccination of infants and young children against rotavirus diarrhea.
Dolin R, Lambert JS, Morse GD, Reichman RC, Plank CS, Reid J, Knupp C, McLaren C, Pettinelli C
2',3'-Dideoxyinosine in patients with AIDS or AIDS-related complex. Rev Infect Dis. 1990 Jul-Aug; 12 Suppl 5:S540-9; discussion S549-51.
2',3'-Dideoxyinosine in patients with AIDS or AIDS-related complex.
Haynes BF, Schooley RT, Grouse JE, Payling-Wright CR, Dolin R, Fauci AS
Journal of immunology (Baltimore, Md. : 1950)
Characterization of thymus-derived lymphocyte subsets in acute Epstein-Barr virus-induced infectious mononucleosis. J Immunol. 1979 Feb; 122(2):699-702.
Characterization of thymus-derived lymphocyte subsets in acute Epstein-Barr virus-induced infectious mononucleosis.
Enterovirus 71--emerging infections and emerging questions. N Engl J Med. 1999 Sep 23; 341(13):984-5.
Enterovirus 71--emerging infections and emerging questions.
HIV vaccine trial results--an opening for further research. N Engl J Med. 2009 Dec 03; 361(23):2279-80.
HIV vaccine trial results--an opening for further research.
Antigenic relatedness among the Norwalk-like agents by serum antibody rises. J Med Virol. 1990 Oct; 32(2):96-101.
Antigenic relatedness among the Norwalk-like agents by serum antibody rises.
Serum antibody levels as risk factors in the dissemination of herpes zoster. Arch Intern Med. 1979 Dec; 139(12):1341-5.
Serum antibody levels as risk factors in the dissemination of herpes zoster.
Novel agents of viral enteritis in humans. J Infect Dis. 1987 Mar; 155(3):365-76.
Novel agents of viral enteritis in humans.
Krogstad DJ, Pearson RD, Bennett JE, Dolin R, Mandell GL
Dosage for malaria treatment. Lancet. 1996 Nov 09; 348(9037):1311; author reply 1311-2.
Drusano GL, Yuen GJ, Morse G, Cooley TP, Seidlin M, Lambert JS, Liebman HA, Valentine FT, Dolin R
Impact of bioavailability on determination of the maximal tolerated dose of 2',3'-dideoxyinosine in phase I trials. Antimicrob Agents Chemother. 1992 Jun; 36(6):1280-3.
Impact of bioavailability on determination of the maximal tolerated dose of 2',3'-dideoxyinosine in phase I trials.
Seidlin M, Lambert JS, Dolin R, Valentine FT
Pancreatitis and pancreatic dysfunction in patients taking dideoxyinosine. AIDS. 1992 Aug; 6(8):831-5.
Pancreatitis and pancreatic dysfunction in patients taking dideoxyinosine.
Raboud JM, Montaner JS, Rae S, Kahn J, Hammer SM, Katzenstein DA, Pavia A, Dolin R, Hughes MD, Cross A, Beltangady M, Gatell J, Dunkle L, Smaldone L
Meta-analysis of five randomized controlled trials comparing continuation of zidovudine versus switching to didanosine in HIV-infected individuals. Antivir Ther. 1997 Dec; 2(4):237-47.
Meta-analysis of five randomized controlled trials comparing continuation of zidovudine versus switching to didanosine in HIV-infected individuals.
Journal of the American Venereal Disease Association
Genital herpes simplex virus type 1 infection--variability in modes of spread. J Am Vener Dis Assoc. 1975 Dec; 2(2):13-6.
Genital herpes simplex virus type 1 infection--variability in modes of spread.
Fischl MA, Richman DD, Hansen N, Collier AC, Carey JT, Para MF, Hardy WD, Dolin R, Powderly WG, Allan JD
The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group. Ann Intern Med. 1990 May 15; 112(10):727-37.
The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.
Reichman RC, Pons VG, Murphy BR, Caplan EA, Dolin R
Cell-mediated cytotoxicity following influenza infection and vaccination in humans. J Med Virol. 1979; 4(1):1-14.
Cell-mediated cytotoxicity following influenza infection and vaccination in humans.
Pons VG, Reinertsen JL, Steinberg AD, Dolin R
Decreased cell-mediated cytotoxicity against virus-infected cells in systemic lupus erythematosus. J Med Virol. 1979; 4(1):15-23.
Decreased cell-mediated cytotoxicity against virus-infected cells in systemic lupus erythematosus.
Treanor JJ, Mattison HR, Dumyati G, Yinnon A, Erb S, O'Brien D, Dolin R, Betts RF
Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly. Ann Intern Med. 1992 Oct 15; 117(8):625-33.
Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly.
Kieburtz KD, Seidlin M, Lambert JS, Dolin R, Reichman R, Valentine F
Journal of acquired immune deficiency syndromes
Extended follow-up of peripheral neuropathy in patients with AIDS and AIDS-related complex treated with dideoxyinosine. J Acquir Immune Defic Syndr (1988). 1992; 5(1):60-4.
Extended follow-up of peripheral neuropathy in patients with AIDS and AIDS-related complex treated with dideoxyinosine.
Development of an enzyme immunoassay for the Hawaii agent of viral gastroenteritis. J Virol Methods. 1988 Dec; 22(2-3):207-14.
Development of an enzyme immunoassay for the Hawaii agent of viral gastroenteritis.
Whitley RJ, Soong SJ, Alford CA, Hirsch MS, Schooley R, Oxman MN, Connor JD, Betts R, Dolin R, Reichman RC
Design of therapeutic studies in herpes simplex encephalitis. Lancet. 1985 Feb 02; 1(8423):284-5.
Design of therapeutic studies in herpes simplex encephalitis.
Whitley RJ, Ch'ien LT, Dolin R, Galasso GJ, Alford CA
Adenine arabinoside therapy of herpes zoster in the immunosuppressed. NIAID collaborative antiviral study. N Engl J Med. 1976 May 27; 294(22):1193-9.
Adenine arabinoside therapy of herpes zoster in the immunosuppressed. NIAID collaborative antiviral study.
Dolin R, Reichman RC, Mazur MH, Whitley RJ
NIH conference. Herpes zoster-varicella infections in immunosuppressed patients. Ann Intern Med. 1978 Sep; 89(3):375-88.
NIH conference. Herpes zoster-varicella infections in immunosuppressed patients.
Keefer MC, Bonnez W, Roberts NJ, Dolin R, Reichman RC
Human immunodeficiency virus (HIV-1) gp160-specific lymphocyte proliferative responses of mononuclear leukocytes from HIV-1 recombinant gp160 vaccine recipients. J Infect Dis. 1991 Mar; 163(3):448-53.
Human immunodeficiency virus (HIV-1) gp160-specific lymphocyte proliferative responses of mononuclear leukocytes from HIV-1 recombinant gp160 vaccine recipients.
Noroviruses--challenges to control. N Engl J Med. 2007 Sep 13; 357(11):1072-3.
Haynes BF, Schooley RT, Payling-Wright CR, Grouse JE, Dolin R, Fauci AS
Emergence of suppressor cells of immunoglobulin synthesis during acute Epstein-Barr virus-induced infectious mononucleosis. J Immunol. 1979 Nov; 123(5):2095-101.
Emergence of suppressor cells of immunoglobulin synthesis during acute Epstein-Barr virus-induced infectious mononucleosis.
Division of Viral Pathogenesis, E/CLS-1003
Truman BI, Madore HP, Menegus MA, Nitzkin JL, Dolin R
Snow Mountain agent gastroenteritis from clams. Am J Epidemiol. 1987 Sep; 126(3):516-25.
Snow Mountain agent gastroenteritis from clams.
Proceedings of the National Academy of Sciences of the United States of America
Production of a monoclonal antibody against the Snow Mountain agent of gastroenteritis by in vitro immunization of murine spleen cells. Proc Natl Acad Sci U S A. 1988 May; 85(10):3613-7.
Production of a monoclonal antibody against the Snow Mountain agent of gastroenteritis by in vitro immunization of murine spleen cells.
Serologic responses after two sequential doses of influenza A/New Jersey/76 virus vaccine in normal young adults. J Infect Dis. 1977 Dec; 136 Suppl:S496-9.
Serologic responses after two sequential doses of influenza A/New Jersey/76 virus vaccine in normal young adults.
Houff SA, Miller GL, Lovell CR, Wallen WC, Madden DL, Sever JL, Dolin R
Transactions of the American Neurological Association
The Guillain-Barré Syndrome and swine influenza vaccination. Trans Am Neurol Assoc. 1977; 102:120-3.
The Guillain-Barré Syndrome and swine influenza vaccination.
Morens DM, Zweighaft RM, Vernon TM, Gary GW, Eslien JJ, Wood BT, Holman RC, Dolin R
A waterborne outbreak of gastroenteritis with secondary person-to-person spread. Association with a viral agent. Lancet. 1979 May 05; 1(8123):964-6.
A waterborne outbreak of gastroenteritis with secondary person-to-person spread. Association with a viral agent.
Human studies in the development of human immunodeficiency virus vaccines. J Infect Dis. 1995 Nov; 172(5):1175-83.
Human studies in the development of human immunodeficiency virus vaccines.
Bagely DH, Alexander JC, Gill VJ, Dolin R, Ketcham AS
Late Flavobacterium species meningitis after craniofacial exenteration. Arch Intern Med. 1976 Feb; 136(2):229-31.
Late Flavobacterium species meningitis after craniofacial exenteration.
Predictors of survival in HIV-infected persons with 50 or fewer CD4 cells/mm3. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Aug 15; 15(5):346-55.
Predictors of survival in HIV-infected persons with 50 or fewer CD4 cells/mm3.
McElrath MJ, Corey L, Montefiori D, Wolff M, Schwartz D, Keefer M, Belshe R, Graham BS, Matthews T, Wright P, Gorse G, Dolin R, Berman P, Francis D, Duliege AM, Bolognesi D, Stablein D, Ketter N, Fast P
A phase II study of two HIV type 1 envelope vaccines, comparing their immunogenicity in populations at risk for acquiring HIV type 1 infection. AIDS Vaccine Evaluation Group. AIDS Res Hum Retroviruses. 2000 Jun 10; 16(9):907-19.
A phase II study of two HIV type 1 envelope vaccines, comparing their immunogenicity in populations at risk for acquiring HIV type 1 infection. AIDS Vaccine Evaluation Group.
Baden LR, Blattner WA, Morgan C, Huang Y, Defawe OD, Sobieszczyk ME, Kochar N, Tomaras GD, McElrath MJ, Russell N, Brandariz K, Cardinali M, Graham BS, Barouch DH, Dolin R
Timing of plasmid cytokine (IL-2/Ig) administration affects HIV-1 vaccine immunogenicity in HIV-seronegative subjects. J Infect Dis. 2011 Nov 15; 204(10):1541-9.
Timing of plasmid cytokine (IL-2/Ig) administration affects HIV-1 vaccine immunogenicity in HIV-seronegative subjects.
Antiviral chemotherapy and chemoprophylaxis. Science. 1985 Mar 15; 227(4692):1296-303.
Antiviral chemotherapy and chemoprophylaxis.
Christy C, Madore HP, Treaner JJ, Pray K, Kapikian AZ, Chanock RM, Dolin R
Safety and immunogenicity of live attenuated rhesus monkey rotavirus vaccine. J Infect Dis. 1986 Dec; 154(6):1045-7.
Safety and immunogenicity of live attenuated rhesus monkey rotavirus vaccine.
The road to an effective HIV vaccine. N Engl J Med. 2012 Apr 05; 366(14):1343-4.
Kapikian AZ, Wyatt RG, Dolin R, Thornhill TS, Kalica AR, Chanock RM
Visualization by immune electron microscopy of a 27-nm particle associated with acute infectious nonbacterial gastroenteritis. J Virol. 1972 Nov; 10(5):1075-81.
Visualization by immune electron microscopy of a 27-nm particle associated with acute infectious nonbacterial gastroenteritis.
Alford CA, Dolin R, Hirsch MS, Karchmer AW, Whitley RJ
Herpes simplex encephalitis and clinical trial design. Lancet. 1982 May 01; 1(8279):1013.
Herpes simplex encephalitis and clinical trial design.
Barouch DH, Kik SV, Weverling GJ, Dilan R, King SL, Maxfield LF, Clark S, Ng'ang'a D, Brandariz KL, Abbink P, Sinangil F, de Bruyn G, Gray GE, Roux S, Bekker LG, Dilraj A, Kibuuka H, Robb ML, Michael NL, Anzala O, Amornkul PN, Gilmour J, Hural J, Buchbinder SP, Seaman MS, Dolin R, Baden LR, Carville A, Mansfield KG, Pau MG, Goudsmit J
International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations. Vaccine. 2011 Jul 18; 29(32):5203-9.
International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations.
From the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, the Center for Disease Control, and the Bureau of Biologics of the Food and Drug Administration. Summary of clinical trials of influenza vaccines--II. J Infect Dis. 1976 Dec; 134(6):633-8.
From the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, the Center for Disease Control, and the Bureau of Biologics of the Food and Drug Administration. Summary of clinical trials of influenza vaccines--II.
Antiviral activity of adenine arabinoside and iododeoxyuridine in human fetal intestinal and tracheal organ cultures. J Infect Dis. 1975 Sep; 132(3):287-95.
Antiviral activity of adenine arabinoside and iododeoxyuridine in human fetal intestinal and tracheal organ cultures.
Duke-Cohan JS, Wollenick K, Witten EA, Seaman MS, Baden LR, Dolin R, Reinherz EL
The heterogeneity of human antibody responses to vaccinia virus revealed through use of focused protein arrays. Vaccine. 2009 Feb 18; 27(8):1154-65.
The heterogeneity of human antibody responses to vaccinia virus revealed through use of focused protein arrays.
Hall CB, Dolin R, Gala CL, Markovitz DM, Zhang YQ, Madore PH, Disney FA, Talpey WB, Green JL, Francis AB
Children with influenza A infection: treatment with rimantadine. Pediatrics. 1987 Aug; 80(2):275-82.
Children with influenza A infection: treatment with rimantadine.
Snyder MH, Clements ML, Betts RF, Dolin R, Buckler-White AJ, Tierney EL, Murphy BR
Evaluation of live avian-human reassortant influenza A H3N2 and H1N1 virus vaccines in seronegative adult volunteers. J Clin Microbiol. 1986 May; 23(5):852-7.
Evaluation of live avian-human reassortant influenza A H3N2 and H1N1 virus vaccines in seronegative adult volunteers.
Buscho R, Wyatt RG, Dolin R, Blacklow NR, DuPont HL, Chanock RM
Recurrent institutional outbreaks of acute infectious nonbacterial gastroenteritis: epidemiology and etiology. Am J Epidemiol. 1973 Sep; 98(3):192-8.
Recurrent institutional outbreaks of acute infectious nonbacterial gastroenteritis: epidemiology and etiology.
Gaining ground in progressive multifocal leukoencephalopathy. Neurology. 1999 Feb; 52(3):440-1.
Gaining ground in progressive multifocal leukoencephalopathy.
Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study. N Engl J Med. 1977 Aug 11; 297(6):289-94.
Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study.
Agus SG, Falchuk ZM, Sessoms CS, Wyatt RG, Dolin R
The American journal of digestive diseases
Increased jejunal IgA synthesis in vitro during acute infectious nonbacterial gastroenteritis. Am J Dig Dis. 1974 Feb; 19(2):127-31.
Increased jejunal IgA synthesis in vitro during acute infectious nonbacterial gastroenteritis.
Viral pneumonias. Med Clin North Am. 1980 May; 64(3):491-506.
Seaman MS, Wilck MB, Baden LR, Walsh SR, Grandpre LE, Devoy C, Giri A, Noble LC, Kleinjan JA, Stevenson KE, Kim HT, Dolin R
Effect of vaccination with modified vaccinia Ankara (ACAM3000) on subsequent challenge with Dryvax. J Infect Dis. 2010 May 01; 201(9):1353-60.
Effect of vaccination with modified vaccinia Ankara (ACAM3000) on subsequent challenge with Dryvax.
Effect of adenine arabinoside on Epstein-Barr virus in vitro. J Infect Dis. 1977 Mar; 135(3):447-53.
Effect of adenine arabinoside on Epstein-Barr virus in vitro.
Studies of the enhancement of an adenovirus-associated virus by herpes simplex virus. J Gen Virol. 1971 Jan; 10(1):29-36.
Studies of the enhancement of an adenovirus-associated virus by herpes simplex virus.
Schooley RT, Haynes BF, Payling-Wright CR, Grouse JE, Dolin R, Fauci AS
Mechanism of Epstein-Barr virus-induced human B-lymphocyte activation. Cell Immunol. 1980 Dec; 56(2):518-25.
Mechanism of Epstein-Barr virus-induced human B-lymphocyte activation.
Influenza: current concepts. Am Fam Physician. 1976 Sep; 14(3):72-7.
Timing of BAL in suspected PCP. J Gen Intern Med. 1994 Jun; 9(6):356.
Walsh SR, Wilck MB, Dominguez DJ, Zablowsky E, Bajimaya S, Gagne LS, Verrill KA, Kleinjan JA, Patel A, Zhang Y, Hill H, Acharyya A, Fisher DC, Antin JH, Seaman MS, Dolin R, Baden LR
Safety and immunogenicity of modified vaccinia Ankara in hematopoietic stem cell transplant recipients: a randomized, controlled trial. J Infect Dis. 2013 Jun 15; 207(12):1888-97.
Safety and immunogenicity of modified vaccinia Ankara in hematopoietic stem cell transplant recipients: a randomized, controlled trial.
Wise TG, Dolin R, Mazur MH, Top FH, Edelman R, Ennis FA
Serologic responses and systemic reactions in adults after vaccination with bivalent A/Victoria/75-A/New Jersey/76 and monovalent B/Hong Kong/72 influenza vaccines. J Infect Dis. 1977 Dec; 136 Suppl:S507-17.
Serologic responses and systemic reactions in adults after vaccination with bivalent A/Victoria/75-A/New Jersey/76 and monovalent B/Hong Kong/72 influenza vaccines.
Williams GW, Steinberg AD, Reinertsen JL, Klassen LW, Decker JL, Dolin R
Influenza immunization in systemic lupus eruthematosus. A double-blind trial. Ann Intern Med. 1978 Jun; 88(6):729-34.
Influenza immunization in systemic lupus eruthematosus. A double-blind trial.
Dolin R, Blacklow NR, Wyatt RG, Sereno MM
Detection and localization of viruses in human fetal intestinal organ cultures by immunofluorescence. Infect Immun. 1972 Dec; 6(6):958-64.
Detection and localization of viruses in human fetal intestinal organ cultures by immunofluorescence.
Herpes zoster at the NIH: a 20 year experience. Am J Med. 1978 Nov; 65(5):738-44.
Herpes zoster at the NIH: a 20 year experience.
Belshe RB, Bolognesi DP, Clements ML, Corey L, Dolin R, Mestecky J, Mulligan M, Stablein D, Wright P
HIV infection in vaccinated volunteers. JAMA. 1994 Aug 10; 272(6):431.
Graham BS, Matthews TJ, Belshe RB, Clements ML, Dolin R, Wright PF, Gorse GJ, Schwartz DH, Keefer MC, Bolognesi DP
Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network. J Infect Dis. 1993 Mar; 167(3):533-7.
Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network.
Grasela TH, Walawander CA, Beltangady M, Knupp CA, Martin RR, Dunkle LM, Barbhaiya RH, Pittman KA, Dolin R, Valentine FT
Analysis of potential risk factors associated with the development of pancreatitis in phase I patients with AIDS or AIDS-related complex receiving didanosine. J Infect Dis. 1994 Jun; 169(6):1250-5.
Analysis of potential risk factors associated with the development of pancreatitis in phase I patients with AIDS or AIDS-related complex receiving didanosine.
Resistance to neuraminidase inhibitors. Clin Infect Dis. 2011 Feb 15; 52(4):438-9.
Dolin R, Roessner KD, Treanor JJ, Reichman RC, Phillips M, Madore HP
Radioimmunoassay for detection of the Snow Mountain Agent of viral gastroenteritis. J Med Virol. 1986 May; 19(1):11-8.
Radioimmunoassay for detection of the Snow Mountain Agent of viral gastroenteritis.
Graham BS, Belshe RB, Clements ML, Dolin R, Corey L, Wright PF, Gorse GJ, Midthun K, Keefer MC, Roberts NJ
Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials Network. J Infect Dis. 1992 Aug; 166(2):244-52.
Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials Network.
Knupp CA, Shyu WC, Dolin R, Valentine FT, McLaren C, Martin RR, Pittman KA, Barbhaiya RH
Pharmacokinetics of didanosine in patients with acquired immunodeficiency syndrome or acquired immunodeficiency syndrome-related complex. Clin Pharmacol Ther. 1991 May; 49(5):523-35.
Pharmacokinetics of didanosine in patients with acquired immunodeficiency syndrome or acquired immunodeficiency syndrome-related complex.
Dolin R, Graham BS, Greenberg SB, Tacket CO, Belshe RB, Midthun K, Clements ML, Gorse GJ, Horgan BW, Atmar RL
The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network. Ann Intern Med. 1991 Jan 15; 114(2):119-27.
The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network.
Effect of virus infection on polymorphonuclear leucocytes. Lancet. 1977 May 21; 1(8021):1110-1.
Effect of virus infection on polymorphonuclear leucocytes.
Morens DM, Bregman DJ, West CM, Greene MH, Mazur MH, Dolin R, Fisher RI
An outbreak of varicella-zoster virus infection among cancer patients. Ann Intern Med. 1980 Sep; 93(3):414-9.
An outbreak of varicella-zoster virus infection among cancer patients.
Blackwelder WC, Dolin R, Mittal KK, McNamara PM, Payne FJ
A population study of herpesvirus infections and HLA antigens. Am J Epidemiol. 1982 Apr; 115(4):569-76.
A population study of herpesvirus infections and HLA antigens.
Influenza A/USSR/77 (H1N1) on a university campus. Am J Epidemiol. 1980 Jan; 111(1):23-30.
Influenza A/USSR/77 (H1N1) on a university campus.